about
Human NK Cell Diversity in Viral Infection: Ramifications of RamificationZika Virus Infection Induces Cranial Neural Crest Cells to Produce Cytokines at Levels Detrimental for NeurogenesisMeasurements of immune responses for establishing correlates of vaccine protection against HIVThe natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infectionAssociation between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adultsEnhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy.Loss of cell cycle controls in apoptotic lymphoblasts of the bursa of Fabricius.Coordinated regulation of NK receptor expression in the maturing human immune system.Hormonal contraception and HIV-1 transmission.Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility.Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza VaccineThe impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.Transmission of HIV-1 in the face of neutralizing antibodies.NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.Genetic and environmental determinants of human NK cell diversity revealed by mass cytometryRedefining Memory: Building the Case for Adaptive NK cells.Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells.The newborn human NK cell repertoire is phenotypically formed but functionally reduced.Increased Proinflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.Delayed BCG vaccination--time to take a shot.Humanized mouse model supports development, function, and tissue residency of human natural killer cells.Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A VirusesMaintaining a Robust Pipeline of Future Physician-ScientistsCorrection: A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation.HLA Upregulation During Dengue Virus Infection Suppresses the Natural Killer Cell ResponseHIV-1 transmission goes retro (steps back)Pregnancy-Induced Alterations in NK Cell Phenotype and FunctionA novel human IL2RB mutation results in T and NK cell-driven immune dysregulationHuman natural killer cells mediate adaptive immunity to viral antigensUniversal Principled Review: A Community-Driven Method to Improve Peer ReviewReinvigorating NIH Grant Peer ReviewA single-cell atlas of the peripheral immune response to severe COVID-19A single-cell atlas of the peripheral immune response in patients with severe COVID-19
P50
Q26765925-A841938C-B1B7-4E0B-B3F7-AE243B922107Q27094488-F52EED3D-68FF-451A-8391-45061268AB2FQ28728189-7C10FEE9-EF96-43A0-A733-CC86263C2602Q29365826-2ED99166-57D8-4C78-AB48-CFE12808EC8EQ33602772-D88A4BB0-06AD-4E70-AC10-DADAED3CBF4CQ34057868-80C94F84-676D-412D-BA26-959F28E19294Q34407590-731C2215-4EB8-4482-9A51-B323265F2F20Q34444076-FE979905-3119-4A02-9D83-D347617B8A57Q34476273-F41B18F0-6746-40BD-91CC-291CA7009525Q34679705-57186D0B-AFF7-4D4D-849D-7BB430E3DE22Q35682690-EA746057-1B24-4B8A-850D-D8C43BC29D4DQ35990726-46EE1C91-C3A8-4D95-8C1B-FF2BA113492BQ35993484-0DCA79FC-A831-4401-92B2-6C3FE51D10A3Q36496904-FA076D95-DF0D-4713-8581-B9F943B8D1FBQ37017806-94C64AD2-6700-408D-A3F0-C59C5CA9E1A3Q37503717-562D8102-C658-4D98-A754-70EA564CDD80Q37569278-1B664410-9C1B-4AE0-B33D-C0FD80EB4420Q38631761-57B7D4C9-F7C1-4BEA-BEFB-4B3261065702Q38785314-A8FB69F5-ADA8-475A-8F76-071172CFDF9CQ40513111-0E393358-8E70-43FE-9552-5005494BEEC7Q40531458-8DBE6E53-BBE1-4103-8CD8-DA040129FAB2Q46828885-91F0EF66-A92E-41D2-8579-22E10B29A413Q47594619-39F97792-7A9A-47DA-A280-17DDBFB6B2D4Q57093491-73F2F98D-D63B-4BB0-8C81-5C2B49729BDDQ57169491-6DD55C33-B66C-4D4E-9678-302E38771902Q64982520-ED6B32C6-F7CC-46E9-AAC1-C7A18E71FB30Q66678840-3D1DED88-7A94-47AC-9D27-A175745578F2Q85009518-BC9B78C6-6C62-45A3-9288-DC4B61E58E8BQ91218236-827714C7-71BB-4CE5-AB31-D3EEBBAAC630Q91651192-28C049CC-8E82-4AB8-8ABB-2FDAF1445401Q91929965-2ECD8C38-1E0C-4301-A4A3-861C879083F6Q91960434-90A866FE-621A-437C-8E1C-2852D22C7DF2Q92658229-7AA7F03F-FEC5-464C-98BC-579AD3CCF970Q95627144-07E196E9-0821-4A89-8BDB-2DFE411DA703Q96230984-0888F244-5C26-44AD-940D-10926B3F7F25
P50
description
researcher ORCID ID = 0000-0001-6946-7627
@en
wetenschapper
@nl
name
Catherine A Blish
@ast
Catherine A Blish
@en
Catherine A Blish
@es
Catherine A Blish
@nl
type
label
Catherine A Blish
@ast
Catherine A Blish
@en
Catherine A Blish
@es
Catherine A Blish
@nl
prefLabel
Catherine A Blish
@ast
Catherine A Blish
@en
Catherine A Blish
@es
Catherine A Blish
@nl
P1153
6602798552
P21
P31
P496
0000-0001-6946-7627